Arizona Tribune - Boulevard

NYSE - LSE

CMSC	-0.84%	21.102	$
BTI	-0.87%	56.21	$
RBGPF	0%	68.56	$
BCE	-0.3%	23.71	$
BP	-0.85%	44.76	$
VOD	-0.31%	15.96	$
NGG	-1.08%	79.76	$
RIO	2.97%	105.3	$
GSK	0.86%	52.41	$
RYCEF	-1.23%	20.25	$
BCC	0.85%	82.47	$
JRI	-0.24%	12.38	$
AZN	0.9%	165.98	$
RELX	1.48%	35.91	$
CMSD	-0.67%	20.98	$

Featured

Swedish police identify 17-year-old girl as victim in school sword attack

Swedish police revealed that a 17-year-old student was the fatal victim of a sword attack at a high school where widespread tributes were paid to her Saturday.

Pope Leo calls for courage in Rimini visit after stop in tiny San Marino

Pope Leo XIV visited the tiny republic of San Marino Saturday and later the Italian seaside resort of Rimini, where he exhorted attendees of an influential cultural and political event to be "courageous pioneers" in fighting inequality and poverty.

Last news

Black Book 2026 Payer Digital Technology Survey Establishes Rigorous 18-KPI Standard for Health Plan IT Client Satisfaction Rankings

Proprietary qualitative model evaluates payer technology, managed services, BPaaS, analytics, AI, cybersecurity, interoperability, clinical operations, administrative operations, and transformation partners through verified user experience and operational evidence

Dr. Ran Rubinstein Brings BioRePeel to Newburgh, NY and Montvale, NJ

Dr. Ran Rubinstein introduces BioRePeel to both New York and New Jersey practices as demand grows for no-downtime skin rejuvenation treatments.

NextBoat Inc. Completes Corporate Rebrand and Begins Trading Under "NXB" on NYSE American

Company accelerates evolution into AI-powered platform transforming how boats are bought and sold

Sunshine Biopharma Announces Issuance of U.S. Patent 12,624,066 B2 Covering Novel Coronavirus Treatment Technology

FORT LAUDERDALE, FL / ACCESS Newswire / May 29, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription medications, today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 12,624,066 B2, titled "Compounds and Methods for Treatment of Coronavirus Infection." The newly granted patent protects Sunshine Biopharma's proprietary therapeutic compounds designed to inhibit coronavirus replication.

American Rebel Light Beer Powers into the NHRA Potomac Nationals this Weekend (May 29-31, 2026) with Tony Stewart Racing, Matt Hagan's Funny Car, and John Hall's Pro Stock Motorcycle

NHRA Potomac Nationals Provide a Powerful Platform for American Rebel Light Beer's Nationwide Expansion Strategy and Multi-Class Racing PresenceMulti-Class NHRA Platform Delivers Coast-to-Coast Broadcast Reach and Trackside Impact for American Rebel Light - America's Patriotic Beer BrandAmerican Rebel-Branded Sponsorship with Tony Stewart Racing, Matt Hagan, Leah Pruett, and John Hall Amplifies National Brand Momentum Across FOX, FS1, and NHRA.tv While Connecting with NHRA's Loyal, Values-Driven Fan Base

MMJ International Holdings Files Formal Challenge To DEA Marijuana Rescheduling As Constitutional, Treaty, And Pharmaceutical Questions Collide

"After Eight Years, Millions invested, FDA INDs, Orphan Drug Designation, DEA Inspections, and a Completed Federal Investigation, MMJ Demands the Government Explain Why Companies That Followed Federal Law Were Left Behind" asked Duane Boise, CEO MMJ International Holdings.

Hemogenyx Pharmaceuticals PLC Announces Grant of Options and Extension of Warrant Term

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.Grant of Options and Extension of Warrant Term

InterContinental Hotels Group PLC Announces Transaction in Own Shares - May 29

LONDON, UK / ACCESS Newswire / May 29, 2026 / The Company announces that on 28 May 2026 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 8 May 2025 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 17 February 2026, as announced on 17 February 2026.

US labels two Brazilian crime groups as terrorist organizations

The United States on Thursday designated two well-known Brazilian crime groups, the so-called Red Command (CV) and First Capital Command (PCC), as terrorist organizations, despite opposition from Brasilia.

Netflix criticises German plan to make streamers invest more locally

Netflix and other streaming services on Thursday criticised a German plan requiring platforms to reinvest a share of locally generated revenue as part of efforts to support domestic film production.

Attacker wounds three at Swiss train station with 'bladed weapon'

A man reportedly shouting "Allahu akbar!" injured three people with a bladed weapon at a train station near Zurich on Thursday, before being arrested, Swiss police said.

France inches towards symbolic repealing of slavery legislation

Lawmakers were moved to tears in parliament Thursday as France inched towards repealing outdated legislation that defines people enslaved in its colonies as "moveable goods", in a symbolic move as the country grapples with its colonial legacy.

Italian police seize $232 mn in late mafia boss's assets

Italy said Thursday it was seizing more than 200 million euros ($232 million) in assets belonging to late Mafia boss Matteo Messina Denaro derived from drug trafficking and reinvested in Europe and beyond.

EU fines Temu 200 mn euros over illegal products

The EU slapped a 200-million-euro ($232 million) fine on Chinese-owned online retailer Temu on Thursday for allowing the sale of illegal products, including dangerous baby toys and defective chargers.

Vanta Announces Strategic Agreement to Support U.S. Peptide Market Entry Through FDA-Registered Supply Chain and Compliant Payment Processing Infrastructure; Advancing U.S.-Focused Longevity and Consumer Health Sciences Platform

News Release Highlights:Vanta enters into strategic operating and infrastructure agreement supporting the planned launch of a U.S.-focused peptide therapy and longevity platform leveraging telehealth-enabled commercialization infrastructure, FDA-registered 503A and 503B compounding pharmacy relationships, peptide manufacturing and fulfillment capabilities, and compliant merchant processing infrastructure designed to support scalable online and in-person payment capabilities.Contemplated U.S. peptide therapy platform intended to operate as an integrated telehealth-enabled wellness and longevity ecosystem supporting scalable digital patient acquisition, clinician consultations, prescription authorization workflows, pharmacy fulfillment, subscription continuity, customer retention, and recurring subscription-oriented revenue generation through a capital-efficient downstream commercialization strategy.Vanta advancing integrated consumer health sciences and longevity ecosystem combining U.S.-focused peptide therapy, nutraceutical, and premium hydration integrated product portfolio positioned to capitalize on growing consumer demand for preventative wellness and healthspan extension initiatives across metabolic optimization, recovery, performance optimization, and healthy aging categories.

American Rebel CEO Andy Ross Appeared Last Night on Dr. Drew, Defending American Freedoms and Celebrating the Spirit of the American Dream

American Rebel Holdings (OTC:AREB) CEO Andy Ross took America's Patriotic Brand™ to Dr. Drew's national audience yesterday - discussing the Second Amendment, Stand Your Ground principles, patriotism, and his new Patriotic Anthem celebrating 250 years of America "Hold my Beer", with the full segment now available to watch on replay

Ownia Collection Launches Summer 2026 Edit: The New Definition of Ultra-Luxury Traveling with Purpose

As 95% of next-gen luxury travelers demand verified eco-credentials, Ownia's curated portfolio proves that ultra-premium hospitality and strict conservation accountability are inseparable.

Pharmacy Podcast Network Recognized Among RXinsider's Pharmacy500 Best Businesses Inside Pharmacy for Third Consecutive Year

Three-year Pharmacy500 recognition highlights Pharmacy Podcast Network's unique role in turning pharmacy media, public relations, podcasting, and targeted content distribution into business-development opportunities across the pharmacy profession.

LogoTags, America's Leading Custom Race Medal and Challenge Coin Company, Sponsors Clemson Race

LogoTags, Trusted Fifth-Generation Family-Owned U.S. Manufacturer, Supports the 2026 South Carolina Tri Series with Premium Custom Challenge Coin

The Naderi Center for Plastic Surgery Weighs In on What the Public Gets Wrong About Deep Plane Facelift Techniques and Longevity

Facial plastic surgeon explains how technique, tissue quality, and healing timelines influence facelift outcomes beyond social media speculation.

Hoover Presidential Foundation Unveils New Logo, Marking a Defining Moment Ahead of August Grand Reopening

WEST BRANCH, IA / ACCESS Newswire / May 28, 2026 / The Hoover Presidential Foundation today announced the introduction of its new logo, a modern identity that reflects a broader, more complete telling of Herbert Hoover's life and legacy. The unveiling comes as the Foundation prepares for the highly anticipated grand reopening of the Herbert Hoover Presidential Library and Museum on August 6, 2026.

SoCal Aesthetic Surgery Named "Best of 2026" by BusinessRate for Excellence in Plastic Surgery

BusinessRate recognition reflects consistently positive patient feedback and trusted facial plastic surgery care in Irvine and throughout Orange County.

Jaguar Health Research in Ethnobotanical Medicine Helps Advance Crofelemer Development for Genetically Defined Rare Congenital Gastrointestinal Disorders

Crofelemer delayed-release tablets are Jaguar's FDA-approved prescription drug under botanical guidance ("botanical drug") derived from the Croton lechleri tree. Crofelemer, in a novel liquid formulation, is being developed as the potential first oral adjunctive therapy for Intestinal Failure (IF) from microvillus inclusion disease (MVID) and short bowel syndrome (SBS)Crofelemer development with novel formulations for different gastrointestinal disorders reflects a differentiated botanical drug platform integrating ethnobotanical medicine, sustainable harvesting, complex CMC, and novel bioassays to support approval under FDA botanical guidanceTraditional knowledge of Croton lechleri use supported ethnobotanical research that led to development and approval of crofelemer, whose first in class anti-secretory mechanism was characterized through modern pharmacology and mechanism-based bioassays. Recent milestones include continued evaluation in an extension phase for Jaguar family company Napo's pivotal clinical trial of crofelemer as adjunctive therapy to Parenteral Support (PS) for MVID and upcoming ESPGHAN presentations in pediatric MVID and SBS-IF patientsFDA approval of crofelemer as an oral botanical drug highlights the totality-of-evidence and creates a significant practical barrier to generic replication

Will Physicians Risk Their Licenses For CMS Hemp Products The FDA Never Approved?

"As SAM (Smart Approaches To Marijuana) and MMJ International Holdings Prepare an Appeal, Medicare Doctors Now Stand Between Seniors and Uncharacterized, Unsafe Hemp Products," stated Duane Boise, CEO MMJ International Holdings.

Sunshine Biopharma Announces Reverse Stock Split to Maintain NASDAQ Listing

FORT LAUDERDALE, FL / ACCESS Newswire / May 28, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription medications, today announced a one for ten reverse split of its common stock, effective at market open on June 1, 2026. The reverse stock split was undertaken to regain compliance with Nasdaq's minimum bid price requirement for continued listing. The reverse stock split will reduce the Company's issued and outstanding shares of common stock from 21,236,346 to approximately 2,123,635.

Medical Care Technologies (OTC PINK:MDCE) Provides Additional Details Regarding MDCE Melanoma Scan Beta Imaging Platform

Company discusses AI-assisted body-map monitoring architecture and long-term imaging technology development initiatives

Patient Safety Movement Foundation Appoints Three Distinguished Leaders to Governance Board

Global nonprofit strengthens leadership with expertise spanning government, medicine, and international healthcare systems in pursuit of zero preventable patient harm

TRNR Updates Investor Presentation Detailing Acquisition Strategy and Increased M&A Pipeline

AUSTIN, TX / ACCESS Newswire / May 28, 2026 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the Wattbike, CLMBR, FORME and Ergatta brands, today published an updated investor presentation detailing its acquisition-driven operating strategy, the contribution of recently completed acquisitions, and an increased M&A pipeline.

Aspire Biopharma Issues Shareholder Letter

ESTERO, FL / ACCESS Newswire / May 28, 2026 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), a biopharmaceutical company developing multi-faceted patent-pending drug delivery technology, today issued the following letter to shareholders from Chief Executive Officer Kraig Higginson.

Phase 1 Equity Announces Its Third Practice Addition of the Year, Bringing on a Multi-Site Orthodontic Practice Located in Texas

CHICAGO, IL / ACCESS Newswire / May 28, 2026 / Phase 1 Equity, a doctor-owned, doctor-led, and doctor-governed platform for orthodontists and pediatric dentists, is excited to welcome another leading multi-site orthodontic practice based in Texas to its growing network.

Black Book to Release 2026 Top Vendor Client Satisfaction Results Ahead of AHIP26 and HFMA Annual Conferences

Thousands of validated payer IT users and provider finance, business office, RCM and reimbursement professionals contribute category-specific evaluations across 90 healthcare technology and managed services functions

Aptevo Therapeutics Appoints Mary J. Janatpour, Ph.D., as Senior Vice President & Chief Scientific Officer

Experienced oncology R&D leader appointed to support Aptevo's expanding oncology pipeline and new radiopharmaceutical development strategy

Arizona Tribune - Boulevard (English)